Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 12, 2022 07:30 ET | Source: Reunion Neuroscience Inc.

Reunion Neuroscience CEO to Participate on Panel at 2022 Horizons Perspectives on Psychedelics Conference

TORONTO, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (TSX: REUN, NASDAQ: REUN) ("Reunion" or the “Company”), a leader in novel serotonergic psychedelic drug development committed to...
October 07, 2022 17:30 ET | Source: Reunion Neuroscience Inc.

Reunion Neuroscience Inc. Announces Executive Changes

TORONTO, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (TSX: REUN, NASDAQ: REUN) ("Reunion" or the “Company”), a leader in novel psychedelic drug development committed to innovating...
October 03, 2022 07:30 ET | Source: Reunion Neuroscience Inc.

Reunion Neuroscience to Participate in the Cantor Neurology & Psychiatry Conference

TORONTO, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (TSX: REUN, Nasdaq: REUN) ("Reunion"), or (“the Company”), a global leader in the discovery and development of innovative...
September 29, 2022 17:20 ET | Source: Reunion Neuroscience Inc.

Reunion Neuroscience Inc. Announces Results of Annual General and Special Shareholder Meeting

TORONTO, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (TSX: REUN, NASDAQ: REUN) ("Reunion" or the “Company”) today announced the results of the votes held at its September 29, 2022...
September 28, 2022 07:30 ET | Source: Reunion Neuroscience Inc.

Reunion Neuroscience Inc. Appoints Greg Mayes as President and Chief Executive Officer

TORONTO, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (TSX: REUN, NASDAQ: REUN) ("Reunion" or the “Company”), a leader in novel psychedelic drug development committed to innovating...
September 08, 2022 08:00 ET | Source: Reunion Neuroscience Inc.

Reunion Neuroscience Inc. to Participate in Upcoming Investor Conferences

TORONTO, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (TSX: REUN, Nasdaq: REUN) ("Reunion"), or (“the Company”), a global leader in the discovery and development of innovative...
August 31, 2022 07:30 ET | Source: Reunion Neuroscience Inc.

Reunion Neuroscience Inc. Announces 2022 Annual General Meeting of Shareholders

TORONTO, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (TSX: REUN, Nasdaq: REUN) ("Reunion"), or (“the Company”), a global leader in the discovery and development of innovative of...
August 16, 2022 12:46 ET | Source: Reunion Neuroscience Inc.

Reunion Neuroscience Inc. to Commence Trading on the Toronto Stock Exchange on August 17, 2022

TORONTO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (formerly, Field Trip Health Ltd., the "Company" or “Reunion”), a global leader in the discovery and development of innovative of...
August 15, 2022 17:10 ET | Source: Reunion Neuroscience Inc.

Reunion Neuroscience Inc. (Formerly Field Trip Health Ltd.) Reports Fiscal First Quarter 2023 Financial Results, Completed Corporate Reorganization on August 11, 2022

Completed corporate reorganization, separating the Field Trip Discovery and Field Trip Health divisions into two separate companies.Field Trip Discovery renamed Reunion Neuroscience Inc. (“Reunion” or...
August 11, 2022 16:28 ET | Source: Reunion Neuroscience Inc.; Field Trip Health & Wellness Ltd.

Field Trip Announces Closing of Plan of Arrangement and $19.9 Million Private Placement Financing

- Field Trip Health Ltd. has been renamed "Reunion Neuroscience Inc." and remains listed on the NASDAQ Stock Market and Toronto Stock Exchange under the ticker symbol "FTRP" with such ticker symbol...